%20and%20Batch%20Production%20Records%20(BPR).png)
Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
This first-in-class complement inhibitor received the approval through a priorit...
Olema Oncology executive receives Fellowship of the Institution of Chemical Eng...
The Department of Health and Social Care (DHSC) will consider the guidance befor...
Product targets active acne using plant-derived ingredients and is now availabl...
HBM7575/SKB575 is designed to target thymic stromal lymphopoietin (TSLP) as well...
Known as Telix Manufacturing Solutions North Melbourne (TMSNM), the site is desc...
Trade agreement provides zero-duty access for pharmaceutical products and medic...
Investment firm acquires orthopaedics and gynaecology-focused pharmaceuticals ...
Company introduces in-house reasoning engine built on operational data across m...
Company aims to support drug discovery, molecular analysis and research across ...
The decision is based on results from the Phase III MAJESTY study, which indicat...
IBI355 is an Fc-silent, third-generation anti-CD40L antibody that is expected to...
Company introduces a non-surgical hair restoration treatment based on exosome t...
Rosof assumes regional leadership role and will also oversee the ASEAN cluster ...
SBT-77-7101 is described as an autologous CAR-Treg cell therapy currently in Pha...
The agreement grants Novartis access to Chai Discovery’s latest AI models, inclu...
